Aptose Biosciences

-$0.07 (-2.57%) Today

+$0.01 (+0.38%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APTO and other ETFs, options, and stocks.

About APTO

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent.

CEO

William G. Rice

Employees

Headquarters

Toronto, Ontario

Founded

1986

APTO Key Statistics

Market Cap

471.92M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.40M

High Today

$2.75

Low Today

$2.55

Open Price

$2.74

Volume

2.65M

52 Week High

$7.27

52 Week Low

$2.55

Analyst Ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

APTO Earnings

-$0.21

-$0.14

-$0.07

-$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Available Aug 3, After Hours